Topical Diclofenac-Loaded Liposomes Ameliorate Laser-Induced Choroidal Neovascularization in Mice and Non-Human Primates

被引:10
作者
Shimazawa, Masamitsu [1 ]
Inoue, Yuki [1 ]
Masuda, Tomomi [1 ]
Onodera, Risako [2 ]
Tahara, Kohei [2 ]
Shimizu, Yoshitaka [3 ]
Mibe, Yasuhiko [4 ]
Tsuruma, Kazuhiro [1 ]
Takeuchi, Hirofumi [2 ]
Hara, Hideaki [1 ]
机构
[1] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Mol Pharmacol, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan
[2] Gifu Pharmaceut Univ, Dept Drug Delivery Technol & Sci, Pharmaceut Engn, Gifu, Japan
[3] Tokai Univ, Dept Appl Biochem, Hiratsuka, Kanagawa, Japan
[4] BioMedCore Inc, Yokohama, Kanagawa, Japan
关键词
Age-related macular degeneration; eye drop; choroidal neovascularization; fluorescein angiograms; diclofenac; liposome; mice; primates; TRIAMCINOLONE ACETONIDE; MACULAR DEGENERATION; EFFICACY; INFLAMMATION; NEPAFENAC; EYEDROPS; DELIVERY; THERAPY; MODEL; EYE;
D O I
10.2174/1567202614666161104115440
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study aimed to evaluate the effect of liposomes loaded with diclofenac, a potent cyclooxygenase (COX)-1 and COX-2 inhibitor, on laser-induced choroidal neovascularization (CNV) in mice and non-human primates (common marmosets). CNV was induced by laser irradiation on the unilateral or bilateral eye of each mouse or common marmoset, respectively, under anesthesia. The CNV was visualized using fluorescence labeling with intravenous injection of fluorescein-conjugated dextran (molecular weight = 2,000 kDa), and quantified in the retinal pigment epithelia (RPE)-choroidal flatmounts. Diclofenac-loaded liposome or diclofenac ophthalmic solution was instillated to the eye surface daily for 14 days and 21 days in mice and common marmosets, respectively. In the mouse CNV model, 0.1% diclofenac-loaded liposome eye drops administered four times a day (q.i.d.) significantly reduced CNV formation in the RPE-choroidal flatmounts compared with those in empty liposome eye drops. Diclofenac-loaded liposome (0.1%) eye drops, administered once a day (s.i.d.), twice a day (b.i.d.), and three times a day (t.i.d.), also reduced CNV formation in a frequency-dependent manner. Furthermore, diclofenac-loaded liposome (0.03% and 0.1%) eye drops administered t.i.d. reduced CNV formation in a dose-dependent manner, significantly so at 0.1%. In the common marmoset CNV model, late hyperfluorescence and leakage by fluorescein angiograms was observed within or beyond the lesion borders at 17 days after laser irradiation, and diclofenac-loaded liposome eye drops (0.1% t.i.d.) tended to attenuate the late hyperfluorescence and leakage. Diclofenac-loaded liposomes had significantly reduced CNV formation in the RPE-choroidal flatmounts at 21 days after laser irradiation. In conclusion, diclofenac-loaded liposome eye drops enhance penetration to the RPE-choroid, and reduce the CNV formation. These results suggest that a drug-loaded liposome is a useful tool for drug delivery into the posterior segment of the eye.
引用
收藏
页码:46 / 52
页数:7
相关论文
共 22 条
[11]   Ranibizumab for neovascular age-related macular degeneration [J].
Rosenfeld, Philip J. ;
Brown, David M. ;
Heier, Jeffrey S. ;
Boyer, David S. ;
Kaiser, Peter K. ;
Chung, Carol Y. ;
Kim, Robert Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1419-1431
[12]   Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye [J].
Sene, Abdoulaye ;
Chin-Yee, David ;
Apte, Rajendra S. .
TRENDS IN MOLECULAR MEDICINE, 2015, 21 (01) :43-51
[13]   Edaravone-Loaded Liposome Eyedrops Protect against Light-Induced Retinal Damage in Mice [J].
Shimazaki, Hiroki ;
Hironaka, Kohei ;
Fujisawa, Takuya ;
Tsuruma, Kazuhiro ;
Tozuka, Yuichi ;
Shimazawa, Masamitsu ;
Takeuchi, Hirofumi ;
Hara, Hideaki .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (10) :7289-7297
[14]   An Experimental Model for Exudative Age-related Macular Degeneration with Choroidal Neovascularization Using the Common Marmoset [J].
Shimazawa, Masamitsu ;
Masuda, Tomomi ;
Nakamura, Shinsuke ;
Miwa, Miki ;
Nakamura, Katsuki ;
Hara, Hideaki .
CURRENT NEUROVASCULAR RESEARCH, 2015, 12 (02) :128-134
[15]   REVIEW OF DICLOFENAC AND EVALUATION OF ITS PLACE IN THERAPY AS A NONSTEROIDAL ANTIINFLAMMATORY AGENT [J].
SKOUTAKIS, VA ;
CARTER, CA ;
MICKLE, TR ;
SMITH, VH ;
ARKIN, CR ;
ALISSANDRATOS, J ;
PETTY, DE .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (11) :850-859
[16]   Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review [J].
Smith, Stephen J. ;
Smith, Brian D. ;
Mohney, Brian G. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (03) :292-297
[17]   Topical nepafenac inhibits ocular neovascularization [J].
Takahashi, K ;
Saishin, Y ;
Saishin, Y ;
Mori, K ;
Ando, A ;
Yamamoto, S ;
Oshima, Y ;
Nambu, H ;
Melia, MB ;
Bingaman, DP ;
Campochiaro, PA .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (01) :409-415
[18]   The effect of triamcinolone acetonide on laser-induced choroidal neovascularization in mice using a hypoxia visualization bio-imaging probe [J].
Takata, Shinsuke ;
Masuda, Tomomi ;
Nakamura, Shinsuke ;
Kuchimaru, Takahiro ;
Tsuruma, Kazuhiro ;
Shimazawa, Masamitsu ;
Nagasawa, Hideko ;
Kizaka-Kondoh, Shinae ;
Hara, Hideaki .
SCIENTIFIC REPORTS, 2015, 5
[19]   Preparation of bromfenac-loaded liposomes modified with chitosan for ophthalmic drug delivery and evaluation of physicochemical properties and drug release profile [J].
Tsukamoto, Toshimasa ;
Hironaka, Kohei ;
Fujisawa, Takuya ;
Yamaguchi, Daiki ;
Tahara, Kohei ;
Tozuka, Yuichi ;
Takeuchi, Hirofumi .
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 8 (02) :104-109
[20]   Efficacy and safety of topical diclofenac in reducing ocular pain after excimer photorefractive keratectomy [J].
Tutton, MK ;
Cherry, PMH ;
Raj, PS ;
Fsadni, MG .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 1996, 22 (05) :536-541